US20030144476A1
(en)
*
|
2000-03-06 |
2003-07-31 |
Pankaj Agarwal |
Novel compounds
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1686174A1
(en)
*
|
2000-06-02 |
2006-08-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
DE60135393D1
(en)
*
|
2000-06-30 |
2008-09-25 |
Zymogenetics Inc |
Allelic variant of the interferon-like protein Zcyto21
|
WO2002004642A1
(en)
*
|
2000-07-12 |
2002-01-17 |
Takeda Chemical Industries, Ltd. |
Novel polypeptide and dna thereof
|
CA2420392A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
JP4503801B2
(en)
*
|
2000-09-08 |
2010-07-14 |
独立行政法人科学技術振興機構 |
Novel human cancer / testis antigen and its gene
|
WO2002052005A1
(en)
|
2000-12-22 |
2002-07-04 |
Kazusa Dna Research Institute Foundation |
Novel genes and proteins encoded thereby
|
JPWO2002061076A1
(en)
*
|
2001-02-01 |
2004-06-03 |
持田製薬株式会社 |
Adiponectin-related protein
|
WO2002074906A2
(en)
*
|
2001-03-16 |
2002-09-26 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
EP1373306A4
(en)
*
|
2001-03-29 |
2005-07-20 |
Incyte Genomics Inc |
Cytoskeletion-associated proteins
|
EP1434592B1
(en)
*
|
2001-04-10 |
2008-11-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
|
US7309760B2
(en)
|
2001-04-17 |
2007-12-18 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
|
AU2002338582A1
(en)
*
|
2001-04-26 |
2002-11-11 |
Gong, Fancheng |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
AUPR470101A0
(en)
*
|
2001-05-02 |
2001-05-24 |
Murdoch Childrens Research Institute, The |
A molecular marker
|
MXPA03010052A
(en)
*
|
2001-05-03 |
2004-04-02 |
Akzo Nobel Nv |
Peptidylarginine deiminase 6.
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
WO2003000727A2
(en)
|
2001-06-21 |
2003-01-03 |
Isis Innovation Limited |
Atopy
|
AU2002326429B2
(en)
|
2001-07-20 |
2007-09-20 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Phenylthiocarbamide (PTC) taste receptor
|
US7833779B2
(en)
|
2001-07-25 |
2010-11-16 |
Jivan Biologies Inc. |
Methods and systems for polynucleotide detection
|
US7340349B2
(en)
|
2001-07-25 |
2008-03-04 |
Jonathan Bingham |
Method and system for identifying splice variants of a gene
|
US20050064543A1
(en)
*
|
2001-08-17 |
2005-03-24 |
Tang Y. Tom |
Secreted proteins
|
US20050176944A1
(en)
*
|
2001-08-17 |
2005-08-11 |
Henry Yue |
Intracellular signaling molecules
|
WO2003023007A2
(en)
|
2001-09-07 |
2003-03-20 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
|
EP1428877A4
(en)
*
|
2001-09-17 |
2004-11-17 |
Takeda Chemical Industries Ltd |
Novel protein and dna thereof
|
US7192705B2
(en)
|
2001-09-19 |
2007-03-20 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Transductin-1 and applications to hereditary deafness
|
US7504222B2
(en)
|
2001-10-31 |
2009-03-17 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
US20040197778A1
(en)
*
|
2002-12-26 |
2004-10-07 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US8124052B2
(en)
*
|
2003-02-10 |
2012-02-28 |
Georgetown University |
Method for identifying targeting domains and methods and compositions comprising the same
|
CA2476518A1
(en)
*
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7642242B2
(en)
|
2002-03-05 |
2010-01-05 |
Genentech, Inc. |
PRO34128 polypeptides
|
US7247446B2
(en)
|
2002-03-05 |
2007-07-24 |
Genentech, Inc. |
PRO34128 nucleic acids
|
DE10211088A1
(en)
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Gene products differentially expressed in tumors and their use
|
DK2799555T3
(en)
|
2002-03-13 |
2017-05-22 |
Genomic Health Inc |
Gene Expression Profiling in Tumor Tissue Biopsies
|
AU2003220920B2
(en)
*
|
2002-03-14 |
2008-11-06 |
National Institute Of Advanced Industrial Science And Technology |
Novel N-Acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and / or tumor
|
EP1576096A4
(en)
*
|
2002-04-23 |
2007-05-23 |
Univ Georgia Res Found |
N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
|
WO2003104394A2
(en)
*
|
2002-05-21 |
2003-12-18 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
IL165669A0
(en)
|
2002-07-29 |
2006-01-15 |
Senomyx Inc |
Identification of a novel bitter taste receptor t2r76
|
WO2004013347A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Curagen Corporation |
Methods of identifying compounds that modulate protein activity
|
DE60325623D1
(en)
*
|
2002-08-14 |
2009-02-12 |
Nat Inst Of Advanced Ind Scien |
NEW N-ACETYLGALACTOSAMINE TRANSFERASES AND THESE CODING NUCLEIC ACIDS
|
EP1536008A4
(en)
*
|
2002-09-13 |
2006-07-19 |
Sankyo Co |
2',5' -oligoadenylate phosphodiesterase
|
JP2006515165A
(en)
*
|
2002-09-16 |
2006-05-25 |
ジェネンテック・インコーポレーテッド |
Novel compositions and methods for the treatment of immune related diseases
|
US7074911B2
(en)
*
|
2002-09-25 |
2006-07-11 |
Board Of Regents, The University Of Texas System |
Endogenous granzyme B in non-immune cells
|
DE60329115D1
(en)
*
|
2002-09-27 |
2009-10-15 |
Dainippon Sumitomo Pharma Co |
TUMORANT PROPERTIES AND USE THEREOF
|
JP4679149B2
(en)
*
|
2002-09-30 |
2011-04-27 |
オンコセラピー・サイエンス株式会社 |
Genes and polypeptides related to human pancreatic cancer
|
KR20050056250A
(en)
*
|
2002-10-18 |
2005-06-14 |
주식회사 엘지생명과학 |
Gene families associated with cancers
|
GB0224436D0
(en)
*
|
2002-10-21 |
2002-11-27 |
Univ Cambridge Tech |
Polypetides methods and means
|
US20070185017A1
(en)
*
|
2002-10-29 |
2007-08-09 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7288642B1
(en)
|
2002-11-07 |
2007-10-30 |
Mayo Foundation For Medical Education And Research |
Sulfotransferase 2B1 pharmacogenetics
|
AU2003295598B2
(en)
*
|
2002-11-15 |
2009-12-24 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
GB0227908D0
(en)
*
|
2002-11-29 |
2003-01-08 |
Univ London |
Cancer related methods and means
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004067716A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
|
AU2007231823B2
(en)
*
|
2003-01-24 |
2011-07-21 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
|
US20080107600A1
(en)
*
|
2003-02-13 |
2008-05-08 |
Taiichi Katayama |
Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same
|
PT1597391E
(en)
|
2003-02-20 |
2008-12-19 |
Genomic Health Inc |
Use of intronic rna to measure gene expression
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
WO2004081170A2
(en)
*
|
2003-03-10 |
2004-09-23 |
Ares Trading S.A. |
Progestin receptor-like protein
|
EP2248899B8
(en)
|
2003-03-19 |
2015-07-15 |
Biogen MA Inc. |
NOGO receptor binding protein
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
ATE551353T1
(en)
*
|
2003-04-04 |
2012-04-15 |
Centre Nat Rech Scient |
PROTEIN WITH FUSOGENIC ACTION, NUCLEIC ACID SEQUENCES CODING FOR THIS PROTEIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
|
US7306910B2
(en)
*
|
2003-04-24 |
2007-12-11 |
Veridex, Llc |
Breast cancer prognostics
|
FR2854640A1
(en)
*
|
2003-05-07 |
2004-11-12 |
Galderma Res & Dev |
Use of polynucleotide probe specific for the PMP 69 gene in diagnosis of psoriasis and to screen for antipsoriatic agents, also therapeutic use by inhibiting PMP 69 expression or activity
|
CA2527321A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
CA2534027A1
(en)
|
2003-06-19 |
2005-01-27 |
Dennis Drayna |
Variants of human taste receptor genes
|
EP3470535B1
(en)
|
2003-06-24 |
2020-04-01 |
Genomic Health, Inc. |
Prediction of likelihood of cancer recurrence
|
WO2005044977A2
(en)
*
|
2003-06-25 |
2005-05-19 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to lung specific genes and proteins
|
CA2530672A1
(en)
*
|
2003-06-27 |
2005-01-06 |
Seikagaku Corporation |
Method of detecting cancer
|
ES2651849T3
(en)
|
2003-07-10 |
2018-01-30 |
Genomic Health, Inc. |
Expression profile and test algorithm for cancer prognosis
|
DE10332854A1
(en)
*
|
2003-07-18 |
2005-02-17 |
Universitätsklinikum der Charité der Humboldt-Universität zu Berlin |
Use of the newly identified human gene 7a5 / prognostin for tumor diagnostics and tumor therapy
|
US20080153104A1
(en)
*
|
2003-08-08 |
2008-06-26 |
Hiroyuki Aburantai |
Gene Overexpressed in Cancer
|
US20070037204A1
(en)
|
2003-08-08 |
2007-02-15 |
Hiroyuki ABURANTAI |
Gene overexpressed in cancer
|
AU2003275958A1
(en)
*
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
CA2475769C
(en)
*
|
2003-08-28 |
2018-12-11 |
Veridex, Llc |
Colorectal cancer prognostics
|
EP1980629A3
(en)
*
|
2003-08-28 |
2008-12-17 |
Ipsogen |
Identification of an erbb2 gene expression signature in breast cancers
|
DE10341812A1
(en)
*
|
2003-09-10 |
2005-04-07 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
DE10345010A1
(en)
*
|
2003-09-22 |
2005-04-28 |
Eike Staub |
Use of the receptor Nifie14, or nucleic acid encoding it, for detecting cancer, or the risk of developing it, also use of Nifie 14 binding agents for diagnosis and treatment of cancer
|
DE10344799A1
(en)
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
GB0322998D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Ares Trading Sa |
Protein
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
EP2386656B1
(en)
|
2003-11-26 |
2013-04-24 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
WO2005052154A1
(en)
*
|
2003-11-27 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
Method of estimating toxicity of drug
|
EP1699937A2
(en)
*
|
2003-12-05 |
2006-09-13 |
Erasmus MC |
Predicting response and outcome of metastatic breast cancer anti-estrogen therapy
|
AU2004309396B2
(en)
|
2003-12-23 |
2010-05-13 |
Genomic Health, Inc. |
Universal amplification of fragmented RNA
|
US20050153352A1
(en)
*
|
2004-01-09 |
2005-07-14 |
Stanley Chang |
Cancer specific gene MG20
|
WO2005076014A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 2 (mglur2)
|
US20080269103A1
(en)
*
|
2004-02-04 |
2008-10-30 |
Heinz Von Der Kammer |
Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease
|
CA2554380C
(en)
*
|
2004-02-17 |
2015-05-19 |
The Hospital For Sick Children |
Mecp2e1 gene
|
US8637236B2
(en)
|
2004-02-17 |
2014-01-28 |
The Hospital For Sick Children |
MECP2E1 gene
|
WO2005078444A1
(en)
*
|
2004-02-18 |
2005-08-25 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1b (mtnr1b)
|
WO2005083437A1
(en)
*
|
2004-02-26 |
2005-09-09 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with integrin-linked kinase 2 (ilk2)
|
US7166433B2
(en)
*
|
2004-03-03 |
2007-01-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Transductin-1 and transductin-2 and applications to hereditary deafness
|
JP4773424B2
(en)
|
2004-03-19 |
2011-09-14 |
イエール ユニバーシティ |
Detection, isolation and use of Renalase (monoamine oxidase C)
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
JP4746537B2
(en)
*
|
2004-03-31 |
2011-08-10 |
第一三共株式会社 |
Gene encoding guanine nucleotide exchange factor and gene product thereof
|
EP2947160B1
(en)
|
2004-04-09 |
2017-07-12 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
WO2005103713A2
(en)
|
2004-04-20 |
2005-11-03 |
Galapagos N.V. |
Methods, compositions and compound assays for inhibiting amyloid-beta protein production
|
PL1759001T3
(en)
|
2004-04-21 |
2011-09-30 |
Alexion Pharma Inc |
Bone delivery conjugates and method of using same to target proteins to bone
|
US20070286854A1
(en)
|
2004-04-28 |
2007-12-13 |
Bayer Healthcare Ag |
Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
WO2005113786A2
(en)
*
|
2004-05-21 |
2005-12-01 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with chymase (cma1)
|
CA2565524A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Applied Research Systems Ars Holding N.V. |
Splice variant of unc5h2
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
US8034553B2
(en)
*
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
WO2006002437A2
(en)
|
2004-06-24 |
2006-01-05 |
Biogen Idec Ma Inc. |
Treatment of conditions involving demyelination
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
US20060008876A1
(en)
|
2004-07-07 |
2006-01-12 |
Shami A S E |
ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
|
ATE540973T1
(en)
*
|
2004-07-22 |
2012-01-15 |
Five Prime Therapeutics Inc |
COMPOSITIONS AND METHODS FOR USING MGD-CDF FOR DISEASE TREATMENT
|
WO2006010516A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 like protein (metap2-like)
|
WO2006022689A1
(en)
*
|
2004-08-06 |
2006-03-02 |
Applera Corporation |
Method and compositions for treating diseases targeting cd51
|
GB0417887D0
(en)
|
2004-08-11 |
2004-09-15 |
Ares Trading Sa |
Protein
|
WO2007011412A2
(en)
*
|
2004-11-05 |
2007-01-25 |
The Government Of The United States Of America, As Represented By The Secretary Of The Navy |
Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood
|
EP1836629B1
(en)
|
2004-11-05 |
2020-03-04 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
WO2006052731A2
(en)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
JP5180582B2
(en)
*
|
2005-02-02 |
2013-04-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Purkinje cell identification method targeting Corl2 gene
|
EP1851543A2
(en)
|
2005-02-24 |
2007-11-07 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
DE102005013846A1
(en)
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
AU2006269458B2
(en)
|
2005-07-08 |
2012-11-08 |
Biogen Ma Inc. |
Sp35 antibodies and uses thereof
|
GB0515180D0
(en)
*
|
2005-07-22 |
2005-08-31 |
Ares Trading Sa |
Protein
|
EP1926747A1
(en)
|
2005-08-12 |
2008-06-04 |
Schering Corporation |
Mcp1 fusions
|
WO2007056674A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Stowers Institute For Medical Research |
Novel nucleic acids and associated diagnostics
|
AU2006315299A1
(en)
|
2005-11-21 |
2007-05-24 |
Yale University |
Methods of regulating renalase (Monoamine Oxidase C)
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
GB0524648D0
(en)
*
|
2005-12-02 |
2006-01-11 |
Ares Trading Sa |
Reeler domain containing protein
|
GB0524984D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Ares Trading Sa |
Cys-rich, cell surface glycoproteins
|
GB0525958D0
(en)
*
|
2005-12-20 |
2006-02-01 |
Ares Trading Sa |
Casein-like secreted protein
|
WO2008054534A2
(en)
|
2006-05-11 |
2008-05-08 |
Quark Pharmaceuticals, Inc. |
Screening systems utilizing rtp801
|
WO2007141796A2
(en)
|
2006-06-09 |
2007-12-13 |
Quark Pharmaceuticals, Inc. |
Therapeutic uses of inhibitors of rtp801l
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
DK2044111T3
(en)
|
2006-06-21 |
2014-11-17 |
Musc Found For Res Dev |
OBJECTIVE TO COMPLEMENT FACTOR H FOR TREATMENT OF DISEASES
|
KR100873382B1
(en)
|
2006-12-21 |
2008-12-10 |
김현기 |
Human protooncogene, protein encoded by same, expression vector containing same, and cell transformed by said vector
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
US20120070444A1
(en)
*
|
2007-01-19 |
2012-03-22 |
Probiodrug Ag |
IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
|
US20100297623A1
(en)
*
|
2007-03-07 |
2010-11-25 |
The Council Of The Queensland Institute Of Medical Research |
NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
US8163709B2
(en)
|
2008-01-28 |
2012-04-24 |
Board Of Regents Of The University Of Texas System |
TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS
|
KR20100124326A
(en)
|
2008-03-14 |
2010-11-26 |
엑사젠 다이어그노스틱스, 인코포레이티드 |
Biomarkers for inflammatory bowel disease and irritable bowel syndrome
|
US20110294682A1
(en)
*
|
2008-04-28 |
2011-12-01 |
The General Hospital Corporation |
Polynucleotides Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risks
|
EP2133433A1
(en)
*
|
2008-06-09 |
2009-12-16 |
Centre Georges François Leclerc |
A method for predicting responsiveness to a treatment with an anti-HER2 antibody
|
JP5726729B2
(en)
*
|
2008-06-25 |
2015-06-03 |
インスティチュート・パスツール・コリアInstitut Pasteur Korea |
Genome-wide visual identification of human cofactors for HIV-1 infection
|
JP2011527572A
(en)
|
2008-07-09 |
2011-11-04 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Composition comprising a LINGO antibody or fragment
|
WO2010022145A2
(en)
*
|
2008-08-19 |
2010-02-25 |
The University Of North Carolina At Chapel Hill |
Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function
|
EP2397157A4
(en)
*
|
2009-02-11 |
2013-05-01 |
Univ Tokyo |
Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
|
AU2010226726B8
(en)
|
2009-03-16 |
2014-08-14 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
|
US8268550B2
(en)
*
|
2009-06-26 |
2012-09-18 |
Massachusetts Institute Of Technology |
Compositions and methods for identification of PARP function, inhibitors, and activators
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
US8435961B2
(en)
|
2009-06-26 |
2013-05-07 |
Massachusetts Institute Of Technology |
Methods and compositions for increasing the activity of inhibitory RNA
|
EP2453906A4
(en)
|
2009-07-02 |
2014-01-15 |
Musc Found For Res Dev |
Methods of stimulating liver regeneration
|
AU2010314931A1
(en)
|
2009-11-05 |
2012-06-21 |
Taligen Therapeutics, Inc. |
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
|
PT105029B
(en)
*
|
2010-03-29 |
2012-09-11 |
Univ Do Minho |
NUCLEIC PEPTIDE ACID PROBE, CASE AND METHOD FOR DETECTING AND / OR QUANTIFYING SALMONELLA AND THEIR APPLICATIONS
|
US10619195B2
(en)
|
2010-04-06 |
2020-04-14 |
Massachusetts Institute Of Technology |
Gene-expression profiling with reduced numbers of transcript measurements
|
AU2011237688B2
(en)
*
|
2010-04-06 |
2015-09-10 |
Dana-Faber Cancer Institute, Inc. |
Gene-expression profiling with reduced numbers of transcript measurements
|
EA201291138A1
(en)
|
2010-04-30 |
2013-05-30 |
Алексион Фарма Интернэшнл Сарл |
METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF VIOLATIONS CONNECTED WITH MATRIX MINERALIZATION
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
AU2011252864B2
(en)
|
2010-05-14 |
2015-11-05 |
The Regents Of The University Of Colorado, A Body Corporate |
Improved complement receptor 2 (CR2) targeting groups
|
WO2011163412A1
(en)
|
2010-06-22 |
2011-12-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Antibodies to the c3d fragment of complement component 3
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
RU2013155509A
(en)
|
2011-05-16 |
2015-06-27 |
Байер Интеллектуэль Проперти Гмбх |
APPLICATION OF CATHEPSIN K INHIBITION FOR TREATMENT AND / OR PREVENTION OF PULMONARY HYPERTENSION AND / OR HEART FAILURE
|
JP2014533493A
(en)
*
|
2011-11-15 |
2014-12-15 |
オンコサイト コーポレーション |
Methods and compositions for the treatment and diagnosis of bladder cancer
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
US9796780B2
(en)
|
2012-05-14 |
2017-10-24 |
Biogen Ma Inc. |
LINGO-2 antagonists for treatment of conditions involving motor neurons
|
JO3623B1
(en)
|
2012-05-18 |
2020-08-27 |
Amgen Inc |
St2 antigen binding proteins
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
WO2014018849A1
(en)
*
|
2012-07-26 |
2014-01-30 |
International Park Of Creativity |
Preparation of biological devices and their use thereof for increasing the production of secondary metabolites from plants
|
WO2014018822A2
(en)
|
2012-07-26 |
2014-01-30 |
Casa Luker S.A. |
Methods for increasing the production of phenolic compounds from theobroma cacao
|
AU2013302441B2
(en)
|
2012-08-17 |
2018-05-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for detecting complement activation
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
CN104178489B
(en)
*
|
2013-05-23 |
2017-09-19 |
安徽医科大学第一附属医院 |
AAGAB gene mutation bodies and its application
|
WO2015177744A1
(en)
*
|
2014-05-21 |
2015-11-26 |
Consiglio Nazionale Delle Ricerche |
A diagnostic marker for paget disease
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
AU2015357551B2
(en)
|
2014-12-05 |
2021-02-25 |
Alexion Pharmaceuticals, Inc. |
Treating seizure with recombinant alkaline phosphatase
|
EP3242893A1
(en)
|
2015-01-08 |
2017-11-15 |
Biogen MA Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
AU2016211447B2
(en)
|
2015-01-28 |
2021-09-23 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
WO2017031114A1
(en)
|
2015-08-17 |
2017-02-23 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of alkaline phosphatases
|
US11229686B2
(en)
|
2015-09-28 |
2022-01-25 |
Alexion Pharmaceuticals, Inc. |
Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasia
|
US11400140B2
(en)
|
2015-10-30 |
2022-08-02 |
Alexion Pharmaceuticals, Inc. |
Methods for treating craniosynostosis in a patient
|
WO2017087866A1
(en)
|
2015-11-20 |
2017-05-26 |
Grand Valley State University |
Nato3 mutant polypeptides and uses thereof
|
US11065306B2
(en)
|
2016-03-08 |
2021-07-20 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
WO2017173413A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Treating muscle weakness with alkaline phosphatases
|
WO2017173395A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
EP3500289A4
(en)
|
2016-08-18 |
2020-05-06 |
Alexion Pharmaceuticals, Inc. |
Methods for treating tracheobronchomalacia
|
KR20190129058A
(en)
|
2017-03-31 |
2019-11-19 |
알렉시온 파마슈티칼스, 인코포레이티드 |
How to treat hypophosphatase (HPP) in adults and adolescents
|
CN110536694A
(en)
|
2017-04-20 |
2019-12-03 |
Atyr 医药公司 |
For treating pulmonary inflammatory composition and method
|
WO2019036484A1
(en)
*
|
2017-08-15 |
2019-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of argininosuccinic aciduria
|
CN110172462B
(en)
*
|
2017-08-20 |
2021-11-30 |
浙江大学 |
Gene with promotion effect on generation and development of tumor, expression product and application thereof
|
JP2021519590A
(en)
|
2018-03-30 |
2021-08-12 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
Glycoprotein production
|